Moreover, TRIB3 inhibition not only promotes cell cycle arrest but also ferroptosis in prostate cancer cells, whereas, overexpression of TRIB3 counteracts the ferroptotic response to palbociclib. This evidence concerns the gene TRIB3 and prostate carcinoma.